Uzüm Nüket, Ataoğlu Gülen Akyol Omür
Pathology Department, Gazi Universitesi School of Medicine, Ankara, Turkey.
Tumori. 2008 May-Jun;94(3):389-97. doi: 10.1177/030089160809400316.
Meningiomas are classified following the WHO system of 2000 into three grades, benign (grade I), atypical (grade II), and anaplastic (grade III). We investigated the relation between tumor grade and Ki-67 and bcl-2.
In the present study, 246 cases of meningioma were reclassified according to the WHO 2000 system. The relationship between tumor grade and morphological parameters like pattern, mitotic index, cellularity, pleomorphism, nucleoli, small cell population with high nucleus/cytoplasmic ratio, necrosis and brain invasion was examined. Follow-up data were available for only 80 patients.
A correlation was found between all morphologic parameters except for brain invasion. These parameters were related to a poor prognosis. There was no statistically significant difference in the prognosis between WHO grade I and grade II, whereas these two grades collectively exhibited significantly better survival than WHO grade III. Immunohistochemical staining for Ki-67 and bcl-2 was performed, and correlations between their expressions and other clinicopathological findings were investigated. Ki-67 and bcl-2 expression was correlated with tumor grade, and the higher the tumor grade, the higher the Ki-67 and bcl-2 expression. In conclusion, tumor grade appeared to be the most important parameter for a prognosis of meningiomas.
Ki-67 and bcl-2 expression might participate in carcinogenesis and when used with the grading system could provide additional benefit in assessing the biological behavior of the tumor.
脑膜瘤根据2000年世界卫生组织(WHO)系统分为三个级别,即良性(I级)、非典型性(II级)和间变性(III级)。我们研究了肿瘤级别与Ki-67和bcl-2之间的关系。
在本研究中,246例脑膜瘤病例根据WHO 2000系统重新分类。研究了肿瘤级别与形态学参数之间的关系,如模式、有丝分裂指数、细胞密度、多形性、核仁、高核质比的小细胞群体、坏死和脑侵袭。仅80例患者有随访数据。
除脑侵袭外,所有形态学参数之间均存在相关性。这些参数与预后不良相关。WHO I级和II级之间的预后无统计学显著差异,而这两个级别总体生存率明显优于WHO III级。进行了Ki-67和bcl-2的免疫组织化学染色,并研究了它们的表达与其他临床病理结果之间的相关性。Ki-67和bcl-2表达与肿瘤级别相关,肿瘤级别越高,Ki-67和bcl-2表达越高。总之,肿瘤级别似乎是脑膜瘤预后最重要的参数。
Ki-67和bcl-2表达可能参与肿瘤发生,与分级系统一起使用时可能在评估肿瘤生物学行为方面提供额外帮助。